Navigation Links
Discovery, Preclinical and Clinical Stage Partnering Terms and Agreements in Pharma and Biotech
Date:11/20/2013

>

Figure 10: Big biotech discovery stage deal frequency – 2007 to 2013

Figure 11: Discovery stage partnering by deal type since 2007

Figure 12: Discovery stage partnering by disease type since 2007

Figure 13: Discovery stage partnering by technology type since 2007

Figure 14: Preclinical stage partnering frequency 2007-2013

Figure 15: Big pharma – top 50 – preclinical stage deals 2007 to 2013

Figure 16: Big pharma preclinical stage deal frequency – 2007 to 2013

Figure 17: Big biotech – top 50 – preclinical stage deals 2007 to 2013

Figure 18: Big biotech preclinical stage deal frequency – 2007 to 2013

Figure 19: Preclinical stage partnering by deal type since 2007

Figure 20: Preclinical stage partnering by disease type since 2007

Figure 21: Preclinical stage partnering by technology type since 2007

Figure 22: Clinical stage partnering frequency 2007-2013

Figure 23: Phase I clinical stage partnering since 2007

Figure 24: Phase II clinical stage partnering since 2007

Figure 25: Phase III clinical stage partnering since 2007

Figure 26: Big pharma – top 50 – clinical stage deals 2007 to 2013

Figure 27: Big pharma clinical stage deal frequency – 2007 to 2013

Figure 28: Big biotech – top 50 – clinical stage deals 2007 to 2013

Figure 29: Big biotech clinical stage deal frequency – 2007 to 2013

Figure 30: Clinical stage partnering by deal type since 2007

Figure 31: Clinical stage partnering by disease type since 2007

Figure 32: Clinical stage partnering by technology type since 2007

Figure 33: Review of upfront payments for discovery, preclinical and clinical stage deals, US$m

Figure 34: Review of milestone payments for discovery, preclinical and clinical stage deals, US$m

Figure 35: Review of royalty paymen
'/>"/>

SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related medicine technology :

1. Ambrx Initiates Collaboration with Bristol-Myers Squibb for Discovery, Development of Next-Generation Antibody Drug Conjugates
2. Regulus Therapeutics Forms Strategic Alliance for Discovery, Development and Commercialization of microRNA Therapeutics with AstraZeneca
3. Antigen Discovery, Inc. Awarded Phase II SBIR Grant to Identify Biomarkers Associated with Protection against Malaria
4. Pressure BioSciences, Inc. and Target Discovery, Inc. Expand Strategic License Agreement and Collaboration Supporting TDIs Planned Offering of Personalized Medicine Clinical Diagnostic Services
5. Regulus Presents Positive Preclinical Data Demonstrating that microRNA-21 Plays an Important Role in Alport Syndrome
6. Positive Preclinical Profile of RG-101, a GalNAc-conjugated anti-miR Targeting microRNA-122, Supports Clinical Development for the Treatment of HCV
7. Data Presented For ENMD-2076 In Preclinical Models Of Triple-Negative Breast Cancer
8. MicroConstants Expands Biomarker Testing and Analysis Services for Preclinical and Clinical Diagnostic Research
9. Lexicon Presents Preclinical Data On LX2761, a New Clinical Candidate for Diabetes Designed to Reduce Glucose Absorption From Gastrointestinal Tract
10. Tumor Immunotherapy Efficacy Increased in Both Breast and Prostate Cancer Preclinical Models with Addition of Galectin Inhibitor
11. Xenon Licenses Antisense Drug XEN701 From Isis and Initiates Preclinical Toxicology Studies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... 2015   Decision Resources Group finds ... less frequent dosing as the highest unmet need ... burden on both patients and providers associated with ... injections, which are the current standard of care. ... is in development for dosing every two to ...
(Date:7/2/2015)... N.C. , July 2, 2015 ... assets related to the ion channel biology platform from ... been obtained as part of Pfizer,s 2011 acquisition of ... rights to the "Icagen" name and trademark.  XRPro Sciences ... services for ion channel and transporter drug discovery, combining ...
(Date:7/2/2015)... July 2, 2015 The report ... Heterofermentative), Species (Lactobacillus, Pediococcus & Enterococcus), Enzymes (Fibre-digesting & ... to 2020", Silage Inoculants & Enzymes Market is expected ... of 4.0% from 2015 to 2020. ... spread through 194 P ages and ...
Breaking Medicine Technology:Retinal Specialists Indicate Strong Desire for DME Therapies Which Induce Greater Vision Gains or are Administered Less Frequently Than Currently Approved Anti-VEGF Therapies 2Retinal Specialists Indicate Strong Desire for DME Therapies Which Induce Greater Vision Gains or are Administered Less Frequently Than Currently Approved Anti-VEGF Therapies 3Icagen Re-launched through XRpro Sciences Acquisition of Pfizer Team and Technology for Ion Channel and Transporter Drug R&D 2Icagen Re-launched through XRpro Sciences Acquisition of Pfizer Team and Technology for Ion Channel and Transporter Drug R&D 3Icagen Re-launched through XRpro Sciences Acquisition of Pfizer Team and Technology for Ion Channel and Transporter Drug R&D 4Silage Inoculants & Enzymes Market Worth $489.05 Million by 2020 2Silage Inoculants & Enzymes Market Worth $489.05 Million by 2020 3Silage Inoculants & Enzymes Market Worth $489.05 Million by 2020 4
... Uroplasty, Inc. (NASDAQ: UPI ), ... markets innovative proprietary products to treat voiding dysfunctions, ... No. 8,046,082 covering the stimulator used in the ... System is an office-based, non-surgical system, used to ...
... LCA-Vision Inc. (NASDAQ: LCAV ), a leading provider ... brand, today announced that management will present at the Lazard ... 2011, at 11:00 a.m. Eastern time. The conference is being ... live and archived webcast of the presentation will be available ...
Cached Medicine Technology:Uroplasty Announces Issuance of New Apparatus Patent for the Urgent® PC Neuromodulation System Stimulator 2
(Date:7/2/2015)... ... July 02, 2015 , ... Hand sanitizers have become extremely popular ... season, according to fresh water advocate and radio host Sharon Kleyne, hand sanitizers can ... that for maximum effectiveness, hand sanitizers must be applied correctly and users must be ...
(Date:7/2/2015)... Kan. (PRWEB) , ... July 02, 2015 , ... ... dedicated exclusively to healthcare providers, has been retained to lead a national ... of the top executive search firms in the healthcare industry, B. E. Smith ...
(Date:7/2/2015)... ... , ... Throughout the month of April, Casey’s General Stores invited customers to ... July 7, Casey’s General Stores Chairman and CEO, Bob Myers, will present a check ... national nonprofit dedicated to restoring a sense of self, restoring the family unit, and ...
(Date:7/2/2015)... ... ... AvePoint Public Sector, Inc., a wholly owned subsidiary of ... it was named the recipient of the 2015 GTRA ConVurge Tech Award for Excellence ... Government Technology Research Alliance (GTRA), was presented June 29 during the ConVurge Honorary Awards ...
(Date:7/2/2015)... ... July 02, 2015 , ... ... development solutions for drugs, biologics and consumer health products, today announced that it ... Dr. Irmgard Neuper is the new General Manager at Catalent’s Schorndorf facility, which ...
Breaking Medicine News(10 mins):Health News:Summer flu season hand sanitizers are most effective when correctly applied reports fresh water advocate Sharon Kleyne 2Health News:Summer flu season hand sanitizers are most effective when correctly applied reports fresh water advocate Sharon Kleyne 3Health News:Nicklaus Children’s Hospital Retains B. E. Smith to Recruit New Chief Operating Officer 2Health News:Nicklaus Children’s Hospital Retains B. E. Smith to Recruit New Chief Operating Officer 3Health News:Casey’s General Stores to Present Donation from “Dog Tag” Campaign to Hope For The Warriors® 2Health News:Casey’s General Stores to Present Donation from “Dog Tag” Campaign to Hope For The Warriors® 3Health News:AvePoint Public Sector Wins 2015 GTRA ConVurge Tech Award for Excellence in Government SaaS 2Health News:AvePoint Public Sector Wins 2015 GTRA ConVurge Tech Award for Excellence in Government SaaS 3Health News:AvePoint Public Sector Wins 2015 GTRA ConVurge Tech Award for Excellence in Government SaaS 4Health News:Catalent Makes Two Key European Appointments in Oral Dose Manufacturing 2
... years experience in vendor, provider and consulting ... ATLANTA, Sept. 18 Health Level Seven (HL7), ... representation, today announced the appointment of John Quinn,as ... reached an,agreement in principle and Quinn, who is ...
... Ill., Sept. 18 American Board of,Medical Specialties ... specialists in the United States, announced at,its Interim ... has,appointed Kevin B. Weiss, MD, MPH, as the ... take up his new duties Dec. 17, 2007,and ...
... - MaxLife Fund Corp. (OTC:,MXFD), is pleased to ... to,its, Advisory Board. Mr. Kahan has an ... He has hands-on experience and knowledge of the,life ... B.Sc. (Honors) in,Mathematics from University College, London, England, ...
... Christina Economos, PhD,principal investigator of Shape Up Somerville: ... curb childhood obesity, will present,her research at the second ... in Boston. "Shape Up Somerville" was a 3 ... graders in the culturally diverse Boston,suburb of Somerville, Massachusetts. ...
... ALEXANDRIA, Va., Sept. 18 Expanded leave,benefits for ... if current,laws are amended to balance the needs ... Human Resource Management (SHRM), the world,s largest,association of ... to ensure leave coverage for members of the,National ...
... 18 DuPont Group Vice,President Mark P. Vergnano ... 37th Annual Investor Conference today that the Safety ... global demands,for products and services that protect lives, ... uniquely positioned to deliver innovations for safety and,security ...
Cached Medicine News:Health News:Health Level Seven Appoints John Quinn as CTO 2Health News:Health Level Seven Appoints John Quinn as CTO 3Health News:ABMS Selects Kevin B. Weiss, MD, MPH, as New President and CEO 2Health News:ABMS Selects Kevin B. Weiss, MD, MPH, as New President and CEO 3Health News:MaxLife Fund Corp. appoints Daniel E. Kahan, to its Advisory Board 2Health News:Success of 'Shape-Up Somerville' Childhood Obesity Intervention to be Presented at the Friedman School Symposium at Tufts, October 29-31, 2007 - Boston 2Health News:SHRM Testimony Urges Congress to Fix FMLA 2Health News:DuPont Focused on Meeting Global Demands for Greater Safety & Protection 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: